Skip to content

Environmental Exposure and Neurological Diseases Questionnaire

Case-control and Population Questionnaire Studying Environmental Risk Factors and Neurological Diseases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02916966
Acronym
Cleveland Ohio
Enrollment
460
Registered
2016-09-28
Start date
2016-10-31
Completion date
2023-09-30
Last updated
2024-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Brief summary

The proposed research is particularly relevant to the National ALS Registry and public environmental health issues because it addresses the potential environmental causes of sporadic ALS. The research will develop an ALS surveillance program in Ohio that can be compared with the national and State-Metro Surveillance Programs of the National ALS Registry, and novel methodologies to determine the role of the cyanobacterial toxin, BMAA (beta-methylamino-L-alanine), and other environmental toxins/toxicants as risk factors for ALS. This work will advance the mission of the Centers for Disease Control Agency for Toxic Substances and Disease Registry (CDC ATSDR) National ALS Registry by offering data on ALS cases in Ohio that address public health concerns over the effects of chronic exposure to cyanobacterial blooms in Lake Erie.

Interventions

Patient Registry

Sponsors

The Cleveland Clinic
CollaboratorOTHER
Dartmouth-Hitchcock Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* ALS * Non-neurodegenerative controls * Can willingly give consent * Over 18 years of age

Exclusion criteria

* Cannot give consent * Under 18 years of age

Design outcomes

Primary

MeasureTime frame
Questionnaire for Environmental Exposures, Toxins, and Neurological Disease1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026